Pulmonary aspergillosis and mucormycosis in a patient with COVID-19

Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, es...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Andre K., Ghazarian, Zeron, Cendrowski, Kristina D., Persichino, Jon G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025540/
https://www.ncbi.nlm.nih.gov/pubmed/33842203
http://dx.doi.org/10.1016/j.mmcr.2021.03.006
_version_ 1783675516370288640
author Johnson, Andre K.
Ghazarian, Zeron
Cendrowski, Kristina D.
Persichino, Jon G.
author_facet Johnson, Andre K.
Ghazarian, Zeron
Cendrowski, Kristina D.
Persichino, Jon G.
author_sort Johnson, Andre K.
collection PubMed
description Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
format Online
Article
Text
id pubmed-8025540
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80255402021-04-07 Pulmonary aspergillosis and mucormycosis in a patient with COVID-19 Johnson, Andre K. Ghazarian, Zeron Cendrowski, Kristina D. Persichino, Jon G. Med Mycol Case Rep Case Report Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU. Elsevier 2021-04-07 /pmc/articles/PMC8025540/ /pubmed/33842203 http://dx.doi.org/10.1016/j.mmcr.2021.03.006 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Johnson, Andre K.
Ghazarian, Zeron
Cendrowski, Kristina D.
Persichino, Jon G.
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
title Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
title_full Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
title_fullStr Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
title_full_unstemmed Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
title_short Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
title_sort pulmonary aspergillosis and mucormycosis in a patient with covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025540/
https://www.ncbi.nlm.nih.gov/pubmed/33842203
http://dx.doi.org/10.1016/j.mmcr.2021.03.006
work_keys_str_mv AT johnsonandrek pulmonaryaspergillosisandmucormycosisinapatientwithcovid19
AT ghazarianzeron pulmonaryaspergillosisandmucormycosisinapatientwithcovid19
AT cendrowskikristinad pulmonaryaspergillosisandmucormycosisinapatientwithcovid19
AT persichinojong pulmonaryaspergillosisandmucormycosisinapatientwithcovid19

Ejemplares similares